Northwest Biotherapeutics Inc. and Canaccord Genuity LLC are seeking to settle claims the brokerage firm placed false stock sale orders to depress Northwest’s stock price, according to a federal court filing.
Judge Gregory H. Woods on Friday asked for a revision to the parties’ proposed court order for voluntary dismissal because the terms of the settlement weren’t disclosed in their letter the previous day.
Six other broker-dealers, including Citadel Securities and Virtu Americas LLC, remain in the lawsuit in the US District Court for the Southern District of New York.
Attorneys for the settling and nonsettling parties didn’t immediately respond ...